Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.
about
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1.Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.Early pregnancy sex steroids and maternal breast cancer: a nested case-control study.Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells.Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer.Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancerAlterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cellsEstrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.Estrogen receptor-β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis.Steroid hormone receptors as prognostic markers in breast cancer.In Situ Evaluation of Estrogen Receptor Dimers in Breast Carcinoma Cells: Visualization of Protein-Protein Interactions.Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling.
P2860
Q26773907-61FAB08A-54BE-4271-B7C2-ACEEE77F4732Q33768248-D88E816B-666E-4C7A-85B4-C3E159E1B92EQ33866151-6C1E4AD2-D6AD-43FB-939C-F6A92C4B53ECQ34621664-44DD4B8E-131A-422A-ACC6-114439EDFD8FQ35271188-100C54FD-72CB-431F-BD7B-4AE74122CD0EQ35585091-C9756C4D-2F7D-4D63-ADA9-ABAE535AB769Q35641661-A24146A6-61B2-4071-A61F-66885DD5DD4BQ35919319-C3BBB302-1C82-4843-BE8B-1780D5FA8595Q36280127-5EC397DC-AB4D-4A8B-8D5F-E00AC7740524Q36962972-D0685A34-A8E1-4D64-92B0-D96160DF551AQ38572516-341F3AFC-0BF2-4CF2-8C17-434FEDA94B88Q38598704-C078A447-5E62-4185-8DE9-044611F71D8CQ41930552-30EB0C9F-F743-4596-ADF8-4A79CCBCB044Q52588451-4CF0CB54-4DC2-42D8-9EBD-CB15DE78330AQ52649598-49AF2969-8047-4505-BA32-7D21637DBED2
P2860
Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Estrogen receptor beta 2 is as ...... pha-negative breast carcinoma.
@en
Estrogen receptor beta 2 is as ...... pha-negative breast carcinoma.
@nl
type
label
Estrogen receptor beta 2 is as ...... pha-negative breast carcinoma.
@en
Estrogen receptor beta 2 is as ...... pha-negative breast carcinoma.
@nl
prefLabel
Estrogen receptor beta 2 is as ...... pha-negative breast carcinoma.
@en
Estrogen receptor beta 2 is as ...... pha-negative breast carcinoma.
@nl
P2093
P2860
P1476
Estrogen receptor beta 2 is as ...... lpha-negative breast carcinoma
@en
P2093
Dimitra J Mitsiou
Dina G Tiniakos
Eugen Dhimolea
Marina Palaiologou
Nikolaos Goutas
Nuiki Iota Chantzi
Stamatis D Vassilaros
Theodoros Filippidis
P2860
P2888
P304
P356
10.1007/S00432-013-1467-4
P577
2013-07-02T00:00:00Z